Current clinical options for the treatment and management of acute respiratory distress syndrome.
暂无分享,去创建一个
[1] Stephen E. Lapinsky,et al. Evaluation of a Ventilation Strategy to Prevent Barotrauma in Patients at High Risk for Acute Respiratory Distress Syndrome , 1999 .
[2] Arthur S Slutsky,et al. Has high-frequency ventilation been inappropriately discarded in adult acute respiratory distress syndrome? , 1998, Critical care medicine.
[3] N. MacIntyre. High-Frequency Ventilation , 2000, Seminars in respiratory and critical care medicine.
[4] G. Meduri,et al. Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial. , 1998, JAMA.
[5] C. Carvalho,et al. Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome. , 1998, The New England journal of medicine.
[6] H. Matsuda,et al. Reduced resuscitation fluid volume for second-degree experimental burns with delayed initiation of vitamin C therapy (beginning 6 h after injury). , 1997, The Journal of surgical research.
[7] W. Beninati,et al. HIGH FREQUENCY OSCILLATORY VENTILATION FOR ADULT RESPIRATORY DISTRESS SYNDROME‐A PILOT STUDY , 1995, Critical care medicine.
[8] J. Repine,et al. Markers for predicting the development of acute respiratory distress syndrome. , 1997, Annual review of medicine.
[9] S. Furukawa. Extracorporeal Support of Oxygenation and Ventilation , 1997, International anesthesiology clinics.
[10] E. Moore,et al. Tracheal gas insufflation is a useful adjunct in permissive hypercapnic management of acute respiratory distress syndrome. , 1996, American journal of surgery.
[11] J. Marini. Evolving concepts in the ventilatory management of acute respiratory distress syndrome. , 1996, Clinics in chest medicine.
[12] P. Parsons,et al. An increase in serum C18 unsaturated free fatty acids as a predictor of the development of acute respiratory distress syndrome. , 1996, Critical care medicine.
[13] A. Anzueto,et al. Aerosolized Surfactant in Adults with Sepsis-Induced Acute Respiratory Distress Syndrome , 1996 .
[14] P. Fridrich,et al. Effectiveness of nitric oxide inhalation in septic ARDS. , 1996, Chest.
[15] R. Dechert,et al. Liquid ventilation in adults, children, and full-term neonates , 1995, The Lancet.
[16] K. Steinberg,et al. Improved survival of patients with acute respiratory distress syndrome (ARDS): 1983-1993. , 1995, JAMA.
[17] J. Arnold,et al. Prospective, randomized comparison of high‐frequency oscillatory ventilation and conventional mechanical ventilation in pediatric respiratory failure , 1994, Critical care medicine.
[18] W. Shoemaker,et al. Cytokine, complement, and endotoxin profiles associated with the development of the adult respiratory distress syndrome after severe injury , 1994, Critical care medicine.
[19] M. Lamy,et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. , 1994, American journal of respiratory and critical care medicine.
[20] M. Yu,et al. A double‐blind, prospective, randomized trial of ketoconazole, a thromboxane synthetase inhibitor, in the prophylaxis of the adult respiratory distress syndrome , 1993, Critical care medicine.
[21] K. Gubler,et al. The intravascular oxygenator (IVOX): preliminary results of a new means of performing extrapulmonary gas exchange. , 1993, The Journal of trauma.
[22] R. Rossaint,et al. Inhaled nitric oxide for the adult respiratory distress syndrome. , 1993, The New England journal of medicine.
[23] P. Herlevsen,et al. Antioxidant treatment with N‐acetylcysteine during adult respiratory distress syndrome: A prospective, randomized, placebo‐controlled study , 1992, Critical care medicine.
[24] M. Couturier,et al. Vitamin E deficiency and lipoperoxidation during adult respiratory distress syndrome , 1990, Critical care medicine.
[25] S. Allen,et al. Effect of a rotating bed on the incidence of pulmonary complications in critically ill patients. , 1988, Critical care medicine.
[26] E. Chi,et al. A monoclonal antibody to the adherence-promoting leukocyte glycoprotein, CD18, reduces organ injury and improves survival from hemorrhagic shock and resuscitation in rabbits. , 1988, The Journal of clinical investigation.
[27] M. Vassar,et al. Prostaglandin E1 and Survival in Patients with the Adult Respiratory Distress Syndrome: A Prospective Trial , 1986, Annals of surgery.
[28] G. Carlon,et al. High-Frequency Jet Ventilation: A Prospective Randomized Evaluation , 1983 .
[29] J. Snyder,et al. Comparison of high frequency jet ventilation to conventional ventilation during severe acute respiratory failure in humans. , 1982 .
[30] Rupert G. Miller,et al. Extracorporeal membrane oxygenation in severe acute respiratory failure. A randomized prospective study. , 1979, JAMA.
[31] R. Brown,et al. Use of extreme position changes in acute respiratory failure , 1976, Critical care medicine.
[32] T L Petty,et al. Acute respiratory distress in adults. , 1967, Lancet.